• Contact Us
  • IND: (+91) 40-485-49062
  • USA: (+1) 614-588-8538

Hyaluronic Acid Viscosupplementation Market Is Projected to Grow at Cagr of 6.36% During the Forecast Period to Reach a Revenue of $2948.78m by 2023

Published By: IndustryARC Published On : 06-May-2019
According to the new market research report by Industry ARC titled “

Hyaluronic Acid Viscosupplementation Market: By Course of Treatment, By Anatomy, By End User, and By Geography Analysis - Forecast (2018 - 2023)

,” the global Hyaluronic Acid Viscosupplementation market is driven by the new technological advancements and collaboration strategies adopted by key players globally.


North America holds the major share in the Hyaluronic Acid Viscosupplementation Market


North America dominated the market with a large market share due to the rising number of arthritis patients in the region. The Centers for Disease Control and Prevention (CDC) estimates that one-third of the U.S. population is obese and obese patients have approximately a greater chance of developing knee osteoarthritis than non-obese patients. North Americans see reimbursement and pricing as the decisive factors for the treatment of hyaluronic acid. However, the APAC region is estimated to grow at the highest CAGR of 7.29% over the forecast period.


Selected/Sample Analysis done in full report


By Course of Treatment, Single Injection has witnessed large growth due to the fact that it is the most commonly used type of treatment as it has its efficacy lasting up to six months in pain relief from knee osteoarthritis. The demand for HA injection has also increased due to its benefits such as significant pain reduction, and improvement in functioning in patients.
By Anatomy type, the Knee Osteoarthritis segment has been recording growth because of the increasing aging population. An estimated 27 million people suffer from knee osteoarthritis in the U.S., which is a clear indication of the widespread prevalence of the disease. Knee osteoarthritis affects nearly one third of the global geriatric population. 


Talk to one of our sales representatives about the full report by providing your details in the link below:


Excerpts on Market Growth Factors


  • Based on region, the Asia-Pacific (APAC) region is estimated to record the highest CAGR due to the increasing prevalence of osteoarthritis cases 
  • Bioventus launched DUROLANE, its single-injection, hyaluronic acid (HA) product used for joint lubrication in the treatment of pain associated with knee osteoarthritis (OA).
  • Increasing demand for minimally invasive surgical procedures, increasing obese population, and rising patient awareness about hyaluronic acid viscosupplementation for the treatment of osteoarthritis drive the market growth.

Key players of the Global Vaccines Market


Bioventus Inc., a Netherland based company that operates in more than 30 countries, offers various types of orthobiologics such as Durolane, Gelsyn 3, and others. The major competitors in this market are LG Chem Ltd., Sanofi Genzyme, Fidia Pharma USA Inc, and Anika Therapeutics, Inc.

The Hyaluronic Acid Viscosupplementation Market is segmented as below: 


A. Hyaluronic Acid Viscosupplementation Market -- By course of treatment

1. By Single injection
2. By Multiple Injection

B. Hyaluronic Acid Viscosupplementation Market -- By Disease Indication

1. Knee Osteoarthritis
2. Hip Osteoarthritis
3. Ankle Osteoarthritis
4. Shoulder Osteoarthritis


C. Hyaluronic Acid Viscosupplementation Market -- By End User

1. Hospitals
2. Clinics
3. Ambulatory Surgical Centers 


D. Hyaluronic Acid Viscosupplementation Market -- By Geography

1. North America
1.1 U.S
1.2 Canada
1.3 Mexico
2. Europe
2.1 U.K
2.2 Germany
2.3 France
2.4 Italy
2.5 Spain 
2.6 Rest of Europe
3. APAC
3.1 China
3.2 Australia
3.3 Japan
3.4 South Korea
3.5 India
3.6 Rest of APAC
4. Rest of World (RoW)
4.1 South America
4.2 Middle East
4.3 Africa


E. Global Vaccines Market -- Market Entropy


F. Companies cited/Interviewed

    LG Chem Ltd.
    Bioventus Inc.
    Sanofi Genzyme
    Fidia Pharma USA Inc.
    Anika Therapeutics, Inc.
    Seikagaku Corporation
    Trb Chemedica International SA. 
    Hangzhou Singclean Medical Products Co., Ltd
    Ferring Pharmaceuticals
    Labrha International


Related Reports:


1. Vaccines Market


2. Medical Robotics Market


About IndustryARC:


IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to supporting the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Contact Us:

Mr. Venkateshwar Reddy
Business Development Manager 

Contact Sales: 

1-614-588-8538 (Ext-101)

Connect with us on LinkedIn

 - https://www.linkedin.com/company/industryarc

Request for Sample

News letter

Type your email below and receive our daily news and updates for free

Need Assistance?

If you have any questions, please contact.

Call Us

(U.S. - Canada toll free)
+1-614-588-8538

Write to Us

(Please send an Email)
sales@industryarc.com